PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.56%
Positive revenue growth while CSIQ is negative. John Neff might see a notable competitive edge here.
-41.96%
Negative gross profit growth while CSIQ is at 104.57%. Joel Greenblatt would examine cost competitiveness or demand decline.
-413.65%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-51.69%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-198.26%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-197.56%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-197.56%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.16%
Share reduction while CSIQ is at 0.95%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.16%
Diluted share count expanding well above CSIQ's 0.06%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
545.05%
OCF growth of 545.05% while CSIQ is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
236.46%
FCF growth of 236.46% while CSIQ is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
7017.95%
Similar 10Y revenue/share CAGR to CSIQ's 7580.58%. Walter Schloss might see both firms benefiting from the same long-term demand.
92.06%
5Y revenue/share CAGR above 1.5x CSIQ's 46.01%. David Dodd would look for consistent product or market expansions fueling outperformance.
-0.79%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
5178.66%
OCF/share CAGR of 5178.66% while CSIQ is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
328.42%
5Y OCF/share CAGR above 1.5x CSIQ's 45.90%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
21.67%
Positive 3Y OCF/share CAGR while CSIQ is negative. John Neff might see a big short-term edge in operational efficiency.
-757.62%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-1985.35%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-12189.31%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
-27.00%
Negative 5Y equity/share growth while CSIQ is at 45.42%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-42.32%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-21.42%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-28.44%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
4.63%
Positive asset growth while CSIQ is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-11.19%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
4.61%
We have some new debt while CSIQ reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
18.15%
We increase R&D while CSIQ cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
46.11%
SG&A declining or stable vs. CSIQ's 168.91%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.